Diabetes mellitus and hearing loss: A review
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Diabetes (type 2) and sensorineural hearing loss are common health problems manifested with ageing. While both type 1 and type 2 diabetes have been associated with hearing loss, a causal link has been difficult to establish. Individuals with diabetes have twice the incidence of hearing loss compared to those without diabetes and those with prediabetes have a 30% higher rate of hearing loss. Whether hearing loss is associated with diabetes independent of glycemic control remains to be determined. Hearing loss has its own set of risk factors and shares others with diabetes. This review will summarize the complex relationship between diabetes and sensorineural hearing loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985 · cited 1×
“Aminoglycoside antibiotics, such as tobramycin, gentamicin, and amikacin, are implicated as the cause of hearing loss in more than 100,000 people annually (Zholudeva et al., 2015).”
BackgroundStandards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896 · cited 2×
“…peptidase-4 inhibitors that increase the half-life of the incretin hormones in the blood stream, which in turn promotes insulin secretion (Drucker and Nauck, 2006); and glucagon-like peptide (GLP)-1 receptor agonists, which stimulate secretion of insulin in response to ingestion of…”
BackgroundDiabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020 · cited 1×
“In the stria vascularis, there were degenerated marginal cells, shrunken intermediate cells, and mitochondrial damage marked by swelling, shrinkage, collapsed cristae, and ruptured walls (Kohn et al., 1991).”
BackgroundGiovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
Menke, A., Casagrande, S., Geiss, L., & Cowie, C. C. (2015) · JAMA · doi:10.1001/jama.2015.10029 · Cited by 2,362 · cited 1×
“Diabetes-related vascular insufficiency often demands increased and repeated antibiotic administration to achieve a medical effect, which can lead to reduced immune responses (Atreja et al., 2019; Mikkelsen et al., 2015) and expose the ear to ototoxicity (Casqueiro et al., 2012).”
BackgroundThe mechanisms of action of metformin
Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.009 · Cited by 1,193 · cited 1×
“Diabetes-related vascular insufficiency often demands increased and repeated antibiotic administration to achieve a medical effect, which can lead to reduced immune responses (Atreja et al., 2019; Mikkelsen et al., 2015) and expose the ear to ototoxicity (Casqueiro et al., 2012).”
BackgroundVounzoulaki, E., Khunti, K., Abner, S. C., Tan, B. K., Davies, M. J., & Gillies, C. L. (2020) · BMJ · doi:10.1136/bmj.m1361 · Cited by 1,150
Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications
Stefan, N., Häring, H.-U., Hu, F. B., & Schulze, M. B. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70062-7 · Cited by 857
The Cardiovascular Biology of Glucagon-like Peptide-1
Drucker, D. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.009 · Cited by 665 · cited 1×
“…in the blood stream, which in turn promotes insulin secretion (Drucker and Nauck, 2006); and glucagon-like peptide (GLP)-1 receptor agonists, which stimulate secretion of insulin in response to ingestion of carbohydrates (Drucker and Nauck, 2006) with cardioprotective actions (Drucker, 2016).”
BackgroundEmerging cancer trends among young adults in the USA: analysis of a population-based cancer registry
Sung, H., Siegel, R. L., Rosenberg, P. S., & Jemal, A. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30267-6 · Cited by 618 · cited 1×
“…is strongly associated with diabetes, sensorineural hearing loss, encephalopathies, seizures, and other morbidities including blindness and stroke, ataxia, psychiatric episodes, and gastrointestinal disturbances (Gerbitz et al., 1995; Murphy et al., 2008; Pickett et al., 2018; Suzuki et al., 1994).”
BackgroundDiabetic nephropathy – complications and treatment
Lim, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s40172 · Cited by 583
BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening
Hsu, W. C., Araneta, M. R. G., Kanaya, A. M., Chiang, J. L., & Fujimoto, W. (2015) · Diabetes Care · doi:10.2337/dc14-2391 · Cited by 500
Deriving ethnic-specific BMI cutoff points for assessing diabetes risk.
Chiu, M., Austin, P. C., Manuel, D. G., Shah, B. R., & Tu, J. V. (2011) · Diabetes Care · doi:10.2337/dc10-2300 · Cited by 398 · cited 3×
“…falls between 23 and 24 kg/m2 (Araneta et al., 2015; Hsu et al., 2015) and similar risk of type 2 diabetes was measured at BMI cutoffs of 30 kg/m2 in white subjects, 24 kg/m2 in South Asian, 25 kg/m2 in Chinese, and 26 kg/m2 in African American subjects in the United States (Chiu et al., 2011).”
Sharma, M., Nazareth, I., & Petersen, I. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010210 · Cited by 291 · cited 1×
“Two decades of research confirmed aspirin as an ototoxic agent that produced a reduction of cochlear emissions, damage to spiral ganglion neurons, and abnormal central processing (McFadden et al., 1984; Sheppard et al., 2014).”
BackgroundPhenotypes of prediabetes and stratification of cardiometabolic risk
Stefan, N., Fritsche, A., Schick, F., & Häring, H.-U. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00082-6 · Cited by 208
Cited by
Low Evidence for Tinnitus Risk Factors: A Systematic Review and Meta-analysis
Biswas, R., Genitsaridi, E., Trpchevska, N., Lugo, A., Schlee, W., Cederroth, C. R., Gallus, S., & Hall, D. A. (2022) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-022-00874-y · Cited by 97
“In the case of diabetes, there is reasonable evidence for a positive association between type 1 and type 2 diabetes and sensorineural hearing loss, and it is suggested that there may be shared risk factors such as glucose processing abnormalities and aging, in addition to some pathologies created by diabetes leading t…”
Background
Metadata
- Authors
- Samocha-Bonet, D., Wu, B., & Ryugo, D. K.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 71
- Pages
- 101423
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W3189498440
- Cited by
- 178
- References
- 19
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.